Reckitt Benckiser Group (RB) PT Lowered to GBX 7,500 at Credit Suisse Group

Reckitt Benckiser Group (LON:RB) had its price objective dropped by equities researchers at Credit Suisse Group from GBX 7,700 ($104.42) to GBX 7,500 ($101.71) in a report released on Monday. The brokerage presently has an “outperform” rating on the stock. Credit Suisse Group’s target price suggests a potential upside of 10.93% from the stock’s current price.

Several other brokerages have also recently commented on RB. JPMorgan Chase & Co. reissued an “overweight” rating and issued a GBX 7,500 ($101.71) price target on shares of Reckitt Benckiser Group in a research report on Tuesday, December 5th. Whitman Howard reissued a “buy” rating and issued a GBX 9,000 ($122.05) price target on shares of Reckitt Benckiser Group in a research report on Monday, October 16th. Morgan Stanley set a £100 ($135.61) price target on shares of Reckitt Benckiser Group and gave the company a “buy” rating in a research report on Wednesday, October 11th. Deutsche Bank reissued a “buy” rating and issued a GBX 8,500 ($115.27) price target on shares of Reckitt Benckiser Group in a research report on Thursday, October 12th. Finally, UBS Group set a GBX 7,250 ($98.32) price target on shares of Reckitt Benckiser Group and gave the company a “neutral” rating in a research report on Wednesday, October 18th. Two equities research analysts have rated the stock with a sell rating, twelve have given a hold rating and nine have assigned a buy rating to the stock. Reckitt Benckiser Group has a consensus rating of “Hold” and an average price target of GBX 7,591.36 ($102.95).

Reckitt Benckiser Group (LON RB) opened at GBX 6,761 ($91.69) on Monday. Reckitt Benckiser Group has a 1 year low of GBX 6,299 ($85.42) and a 1 year high of GBX 8,110.43 ($109.99). The company has a market cap of $47,230.00 and a P/E ratio of 2,261.20.

In related news, insider Adrian Nevil Hennah purchased 2,285 shares of the business’s stock in a transaction that occurred on Wednesday, November 8th. The shares were purchased at an average cost of GBX 6,567 ($89.06) per share, for a total transaction of £150,055.95 ($203,493.29). Also, insider Christopher Sinclair purchased 2,800 shares of the business’s stock in a transaction that occurred on Wednesday, November 1st. The shares were bought at an average price of GBX 6,597 ($89.46) per share, for a total transaction of £184,716 ($250,496.34).

COPYRIGHT VIOLATION WARNING: This story was first published by American Banking News and is the property of of American Banking News. If you are accessing this story on another website, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this story can be accessed at https://www.americanbankingnews.com/2018/01/29/credit-suisse-group-analysts-give-reckitt-benckiser-group-rb-a-gbx-7500-price-target.html.

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc is a manufacturer and marketer of health, hygiene and home products. The Company’s segments include ENA and DvM. The ENA segment consists of Europe, Russia/Commonwealth of Independent States (CIS), Israel, North America, Australia and New Zealand. The DvM segment consists of North Africa, Middle East (excluding Israel) and Turkey, Africa, South Asia, North Asia, Latin America, Japan, Korea and the Association of Southeast Asian Nations (ASEAN).

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply